0001493152-25-027270.txt : 20251211 0001493152-25-027270.hdr.sgml : 20251211 20251211170022 ACCESSION NUMBER: 0001493152-25-027270 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251211 DATE AS OF CHANGE: 20251211 EFFECTIVENESS DATE: 20251211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Oncotelic Therapeutics, Inc. CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-566562 FILM NUMBER: 251565649 BUSINESS ADDRESS: STREET 1: 29397 AGOURA RD. STREET 2: #107 CITY: AGUORA HILLS STATE: CA ZIP: 91301 BUSINESS PHONE: 650-635-7000 MAIL ADDRESS: STREET 1: 29397 AGOURA RD. STREET 2: #107 CITY: AGUORA HILLS STATE: CA ZIP: 91301 FORMER COMPANY: FORMER CONFORMED NAME: MATEON THERAPEUTICS INC DATE OF NAME CHANGE: 20160613 FORMER COMPANY: FORMER CONFORMED NAME: OXIGENE INC DATE OF NAME CHANGE: 19930628 D 1 primary_doc.xml X0708 D LIVE 0000908259 Oncotelic Therapeutics, Inc. 29397 AGOURA ROAD SUITE 107 AGOURA HILLS CA CALIFORNIA 91301 650-635-7000 DELAWARE None MATEON THERAPEUTICS INC OXIGENE INC Corporation true VUONG TRIEU 29397 AGOURA ROAD SUITE 107 AGOURA HILLS CA CALIFORNIA 91301 Executive Officer Director Biotechnology No Revenues 06b false 2025-12-04 false true true true false 25000 J.H. DARBIE & CO 000043520 J.H. DARBIE & CO 000043520 48 WALL STREET NEW YORK NY NEW YORK 10005 All States false 12500000 275000 12225000 true 0 4 1875000 true 0 true Assuming all $12.5 million is raised. J.H. Darbie & Co earn 15% commission + 10% warrants 10625000 true Assuming all $12.5 million is raised and J.H. Darbie & Co earns 15% commission true Oncotelic Therapeutics, Inc. /s/ VUONG TRIEU VUONG TRIEU CEO 2025-12-11